Connect with us


New data available on home care and mental health and addictions




Reading Time: 4 minutes


Canadians now have more information about home and community care and mental health and addictions services in their province or territory. Today, the Canadian Institute for Health Information (CIHI) released 3 new indicators that show how Canada’s health systems are faring when it comes to how many Canadians

  • Are hospitalized because of harm caused by substance use
  • Seek frequent emergency room (ER) care for help with mental health and/or addictions
  • Have their hospital stay extended because the right home and community care services and supports are not ready

These indicators are the first 3 of 12 chosen by the federal, provincial and territorial health ministries, in consultation with Canadians, to measure access to mental health and addictions services and to home and community care.

“The development of these new indicators has been a major collaborative effort between the ministries, system experts, CIHI and people with lived experiences. While it will take time for improvement efforts to be reflected in the indicators, health system decision-makers now have more tools to start discussions about how to target services and measure improvements, as well as to make better evidence-based decisions about how to deliver care to Canadians. CIHI is proud to be part of this effort to increase our knowledge of the mental health and addictions and home care sectors, which are very important services for all of us.”

—   David O’Toole, President and CEO, Canadian Institute for Health Information

“The Government of Canada has now signed bilateral agreements with all provinces and territories, setting out the details of ‎how federal investments to improve access to home and community care and mental health and addictions services will be spent. I believe it is important that Canadians see the results for investments in these priority areas. The indicators released today will serve as an initial set of invaluable metrics to help track improvements to access needed health services for all Canadians.”

—   Ginette Petitpas Taylor, Minister of Health

“All governments and system providers recognize the need to make home and community care and mental health services more accessible. The hospital-based indicators released today are a starting point to launch the discussion about access based on existing available data for these sectors. CIHI is committed to working with our partners to collect and report on additional data in community-based sectors.”

—   Kathleen Morris, Vice President, Research and Analysis, Canadian Institute for Health Information

This first year of results provides a baseline against which to track improvements over time. It will take time for new investments and renewed focus to have an impact on indicator results.

The indicator results are available in the Your Health System: In Brief web tool at the provincial and territorial levels. A companion report is available to provide context and assist with interpretation.

Indicator highlights

Hospital Stays for Harm Caused by Substance Use

This indicator measures how many hospital stays are a direct result of substance use, including alcohol, cannabis, cocaine and other drugs.

The first-year results, based on 2017–2018 data, show the following:

  • Every day, more than 400 Canadians were hospitalized due to harm caused by alcohol or drugs, more than the number of hospital stays for heart attacks and strokes combined.
  • 2 out of 3 of these hospital stays were for men.
  • About 40% of Canadians who had hospital stays caused by substance use also had a mental health condition such as anxiety, depression or schizophrenia.
  • Alcohol consumption was the top cause of hospitalization for harm attributed to substance use across all jurisdictions, accounting for more than half of these hospital stays. After alcohol, cannabis and opioids were among the top drugs leading to hospital stays for substance use in adults. For children and youth, these hospital stays were more likely to be caused by cannabis than by alcohol or other substances.

This hospital-based indicator represents only some of the services needed by individuals with substance use and addictions issues. Substance use and addictions are complex, and this indicator reflects long-term outcomes of public health efforts, and community and social services. It also reflects the needs of different populations, which are impacted by factors such as income, education, social networks, housing, and personal and/or intergenerational trauma.

Frequent Emergency Room Visits for Help With Mental Health and/or Addictions

This indicator measures how many Canadians visited the ER 4 or more times in 1 year. Many factors can influence these indicator results, including the needs and characteristics of the population as well as community-based health and social programs.

In jurisdictions where ER data is available, the analysis found the following:

  • 1 in 10 Canadians who visited an ER for help with mental health and/or addictions did so at least 4 times in 1 year.
  • Half of these frequent ER visits were related to patients who were treated for both a mental health condition and an addiction.
  • Half of frequent ER users who visited for help with mental health and/or addictions were younger than 35.

Due to partial data coverage in some provinces and territories, data for this indicator is not yet comparable.

Hospital Stay Extended Until Home Care Services or Supports Ready

Home care is a vital service for many Canadians who need assistance but do not require hospital care. This indicator measures the number of days patients remain in hospital while waiting for home care services or supports to be ready.

According to the data,

  • More than 90% of hospital patients had access to home care services as soon as they were ready to be discharged from hospital. But 1 in 12 had their stay extended because the services or supports were not ready.
    • This is the equivalent of 3 large hospitals filled each day with people who did not need hospital care.
  • A typical extended stay was 7 days or less, but 1 in 10 extended stays was 39 days or more.
  • Patients with extended hospital stays tend to be older women.

New results for health system performance indicators

In addition to the release of the 3 new indicators measuring access to mental health and addictions and home care services, CIHI has also updated the results for 31 existing health system performance indicators and contextual measures in the Your Health System web tool and Health Indicators e-publication.


SOURCE Canadian Institute for Health Information


SLANG Worldwide to Participate in Investor Events




Toronto, Ontario–(Newsfile Corp. – August 7, 2020) – SLANG Worldwide Inc. (CSE: SLNG), (“SLANG” or the “Company“), a leading global cannabis consumer packaged goods (CPG) company with a diversified portfolio of popular brands, today announced its participation in upcoming investor conferences.

August 12: Canaccord Genuity 40th Annual Growth Conference

SLANG CEO Chris Driessen will present at 10:00am EDT and be available for investor meetings, along with other members of the executive team.

August 18: Benzinga Virtual Cannabis Capital Conference

SLANG CEO Chris Driessen will participate in a fireside chat at 1:05pm EDT titled “Adaptability in Business – When and Where to Apply Capital or Pull it Back.”

Mr. Driessen has also joined the Benzinga Cannabis Advisory Council, comprised of thought leaders from different segments in the industry who come together to share their knowledge, connections and expertise with the Benzinga community.

The Company will post details of these and other events on its website, including links to any available webcasts, when they become available. Investors who wish to receive SLANG news releases, monthly newsletters and other information are encouraged to subscribe to the Company’s investor email list though its website.

Media and Investor inquiries

About SLANG Worldwide Inc.

SLANG Worldwide Inc. is a global leader in the cannabis CPG sector with a diversified portfolio of popular brands distributed across the United States. The Company specializes in acquiring and developing market-proven regional brands as well as launching innovative new brands to seize global market opportunities. SLANG is listed on the Canadian Securities Exchange under the ticker symbol SLNG. For more information, please visit

Forward-Looking Statements

This news release contains statements that constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur.

Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management of SLANG at this time, are inherently subject to significant business, economic and competitive risks, uncertainties and contingencies that could cause actual results to differ materially from those expressed or implied in such statements. Investors are cautioned not to put undue reliance on forward-looking statements. Applicable risks and uncertainties include, but are not limited to regulatory risks, risks related to the COVID-19 global pandemic, changes in laws, resolutions and guidelines, market risks, concentration risks, operating history, competition, the risks associated with international and foreign operations and the other risks identified under the headings “Risk Factors” in SLANG’s final long form prospectus dated January 17, 2019 and “Risks and Uncertainties” in the management discussion and analysis for the year ended December 31, 2019 and three months ended March 31, 2020, each as filed on SEDAR at SLANG is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

To view the source version of this press release, please visit

Continue Reading


PAOG CEO Interview: Cannabis Pharmaceutical Development; Acquired Revenue; Updated Financials; Why PPS Is Undervalued and Timing of Anticipated Correction




Sandusky, Ohio–(Newsfile Corp. – August 7, 2020) – PAO Group, Inc. (OTC Pink: PAOG) today announced an interview of CEO James C. DiPrima on MoneyTV with Donald Baillargeon. The interview is available on the MoneyTV website discussing new cannabis pharmaceutical developments, a recently acquired revenue stream, upcoming financial reports bringing the company current with OTC Markets and discussing why the current price per share (PPS) of PAOG is undervalued and what event is anticipated to correct the valuation . Mr. DiPrima also appeared on MoneyTV last week following PAOG’s acquisition of two medical cannabis companies.

PAOG New Logo

Cannot view this image? Visit:

To view an enhanced version of this graphic, please visit:

Interview Highlights:

Mr. DiPrima discusses PAOG’s partnership with a Contract Research Organization (CRO) and a formal agreement in the works to advance an Investigational New Drug Application (IND) to ultimately achieve Food and Drug Administration (FDA) approval for RespRx (one of the two acquisitions executed by PAOG last week) as a COPD treatment.

Based on positive results from an informal trial of RexpRx with 25 COVID-19 patients, PAOG also plans to make Coronavirus Treatment Acceleration Program (CTAP) application after entering into a CRO agreement.

The COPD treatment, RespRx, is derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled, “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.”

Mr. DiPrima confirms a recently published new PAOG website and the coming publication of PAOG’s financial reports. He further confirms the company now has a revenue base with the acquisition of a cannabis cultivation operation from Puration, Inc. (PURA). Mr. DiPrima concludes the interview with a discussion of why he believes the PPS is undervalued and that he anticipates a PPS correction when the PAOG financials are published.

MoneyTV with Donald Baillargeon is the internationally syndicated television program all about money and what makes it happen, featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures. MoneyTV is seen in over 200 million TV households in more than 75 countries.

The MoneyTV Interview is available at and will be syndicated across multiple channels and platforms.

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.


Contact Us:
Jim DiPrima

To view the source version of this press release, please visit

Continue Reading


PURA Announces Dividend Declaration Date and Anticipated Date of Record




Dallas, Texas–(Newsfile Corp. – August 7, 2020) – Puration, Inc. (OTC Pink: PURA) today announced plans for a formal declaration of a dividend distribution this coming Monday, August 10, 2020. The dividend declaration is expected to be announced the following day, on Tuesday, August 11, 2020. The plan is for the dividend distribution date of record, or the day on which a shareholder must own stock to be eligible for the dividend to promptly follow the declaration date. The declaration date is subject to regulatory approval and the specific date will be released accordingly. The plan is also to pay the dividend promptly. The payment execution is subject to the payment process which involves the transfer agent(s) for the distributed stock and the broker network.

The planned dividend distribution to PURA shareholders results from the recent sale of PURA’s cannabis cultivation operation to PAO Group, Inc. (OTC Pink: PAOG).

The cannabis cultivation operation was sold last week in exchange for PAOG common stock. The stock is slated to be distributed to PURA shareholders in a dividend distribution. The planned distribution ratio is 1 for 1. Accordingly, PURA shareholders will receive one share of PAOG stock in exchange for every PURA share held.

For more information on Puration, visit

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.
Brian Shibley,
(800) 861-1350

To view the source version of this press release, please visit

Continue Reading

Trending Online

Grassnews is part of PICANTE Media and Events, a leading media and boutique event organizer in the European Union with a monthly reach of +50,000 readers. The official company (PROSHIRT SRL), has been listed for 4 years in a row among the top 3 Advertising and market research agencies in the local Top Business Romania Microcompanies based on the Financial Reports. Grassnews digests / hand picks the latest news about the CBD / Legal Cannabis industry and serves them to you daily.

Contact us:

Editorial / PR Submissions

© Grassnews .com 2019 - 2020 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania